My NCBI | Sign In
RSS Settings
  • Search: Appel GB[au]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 124

    1.

    Influence of race/ethnicity on response to lupus nephritis treatment: the ALMS study.

    Isenberg D, Appel GB, Contreras G, Dooley MA, Ginzler EM, Jayne D, Sánchez-Guerrero J, Wofsy D, Yu X, Solomons N.

    Rheumatology (Oxford). 2009 Nov 20. [Epub ahead of print]PMID: 19933596 [PubMed - as supplied by publisher]

    2.

    Mycophenolate mofetil and intravenous cyclophosphamide are similar as induction therapy for class V lupus nephritis.

    Radhakrishnan J, Moutzouris DA, Ginzler EM, Solomons N, Siempos II, Appel GB.

    Kidney Int. 2009 Nov 4. [Epub ahead of print]PMID: 19890271 [PubMed - as supplied by publisher]Related articles

    3.

    Proliferative glomerulonephritis with monoclonal IgG deposits.

    Nasr SH, Satoskar A, Markowitz GS, Valeri AM, Appel GB, Stokes MB, Nadasdy T, D'Agati VD.

    J Am Soc Nephrol. 2009 Sep;20(9):2055-64. Epub 2009 May 21.PMID: 19470674 [PubMed - indexed for MEDLINE]Related articles

    4.

    Renal biopsy in the very elderly.

    Moutzouris DA, Herlitz L, Appel GB, Markowitz GS, Freudenthal B, Radhakrishnan J, D'Agati VD.

    Clin J Am Soc Nephrol. 2009 Jun;4(6):1073-82. Epub 2009 May 14.PMID: 19443626 [PubMed - indexed for MEDLINE]Related articles

    5.

    Mycophenolate mofetil versus cyclophosphamide for induction treatment of lupus nephritis.

    Appel GB, Contreras G, Dooley MA, Ginzler EM, Isenberg D, Jayne D, Li LS, Mysler E, Sánchez-Guerrero J, Solomons N, Wofsy D; Aspreva Lupus Management Study Group.

    J Am Soc Nephrol. 2009 May;20(5):1103-12. Epub 2009 Apr 15.PMID: 19369404 [PubMed - indexed for MEDLINE]Related articles

    6.

    An update on the use of mycophenolate mofetil in lupus nephritis and other primary glomerular diseases.

    Appel AS, Appel GB.

    Nat Clin Pract Nephrol. 2009 Mar;5(3):132-42. Epub 2009 Jan 27. Review.PMID: 19174771 [PubMed - indexed for MEDLINE]Related articles

    7.

    Dense deposit disease: clinicopathologic study of 32 pediatric and adult patients.

    Nasr SH, Valeri AM, Appel GB, Sherwinter J, Stokes MB, Said SM, Markowitz GS, D'Agati VD.

    Clin J Am Soc Nephrol. 2009 Jan;4(1):22-32. Epub 2008 Oct 29.PMID: 18971369 [PubMed - indexed for MEDLINE]Related articles

    8.

    NPHS2 variation in focal and segmental glomerulosclerosis.

    Tonna SJ, Needham A, Polu K, Uscinski A, Appel GB, Falk RJ, Katz A, Al-Waheeb S, Kaplan BS, Jerums G, Savige J, Harmon J, Zhang K, Curhan GC, Pollak MR.

    BMC Nephrol. 2008 Sep 29;9:13.PMID: 18823551 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Pauci-immune crescentic glomerulonephritis superimposed on diabetic glomerulosclerosis.

    Nasr SH, D'Agati VD, Said SM, Stokes MB, Appel GB, Valeri AM, Markowitz GS.

    Clin J Am Soc Nephrol. 2008 Sep;3(5):1282-8. Epub 2008 May 28. Erratum in: Clin J Am Soc Nephrol. 2009 Feb;4(2):516. PMID: 18508945 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    The treatment of acute interstitial nephritis: More data at last.

    Appel GB.

    Kidney Int. 2008 Apr;73(8):905-7.PMID: 18379525 [PubMed - indexed for MEDLINE]Related articles

    11.

    Recurrent glomerulonephritis after renal transplantation: an unsolved problem.

    Golgert WA, Appel GB, Hariharan S.

    Clin J Am Soc Nephrol. 2008 May;3(3):800-7. Epub 2008 Feb 13. Review.PMID: 18272827 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Functional genetic variation in aminopeptidase A (ENPEP): lack of clear association with focal and segmental glomerulosclerosis (FSGS).

    Tonna S, Dandapani SV, Uscinski A, Appel GB, Schlöndorff JS, Zhang K, Denker BM, Pollak MR.

    Gene. 2008 Feb 29;410(1):44-52. Epub 2007 Dec 3.PMID: 18206321 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Effect of LDL cholesterol and treatment with losartan on end-stage renal disease in the RENAAL study.

    Tershakovec AM, Keane WF, Zhang Z, Lyle PA, Appel GB, McGill JB, Parving HH, Cooper ME, Shahinfar S, Brenner BM.

    Diabetes Care. 2008 Mar;31(3):445-7. Epub 2007 Dec 10.PMID: 18070995 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Rituximab treatment of dysproteinemias affecting the kidney: a review of three cases.

    Bhat P, Weiss S, Appel GB, Radhakrishnan J.

    Am J Kidney Dis. 2007 Oct;50(4):641-4.PMID: 17900464 [PubMed - indexed for MEDLINE]Related articles

    15.

    Mycophenolate mofetil for the treatment of interstitial nephritis.

    Preddie DC, Markowitz GS, Radhakrishnan J, Nickolas TL, D'Agati VD, Schwimmer JA, Gardenswartz M, Rosen R, Appel GB.

    Clin J Am Soc Nephrol. 2006 Jul;1(4):718-22. Epub 2006 Apr 26.PMID: 17699278 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    To treat or not to treat IgA nephropathy? That is the question!

    Appel GB.

    Clin J Am Soc Nephrol. 2006 May;1(3):347-8. Epub 2006 Mar 22. No abstract available. PMID: 17699228 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Update on the treatment of lupus nephritis.

    Waldman M, Appel GB.

    Kidney Int. 2006 Oct;70(8):1403-12. Epub 2006 Aug 23. Review.PMID: 16929249 [PubMed - indexed for MEDLINE]Related articles

    18.

    The IgA nephropathy treatment dilemma.

    Appel GB, Waldman M.

    Kidney Int. 2006 Jun;69(11):1939-44. Review.PMID: 16641925 [PubMed - indexed for MEDLINE]Related articles

    19.

    Multiple myeloma, nephrotic syndrome and crystalloid inclusions in podocytes.

    Nasr SH, Preddie DC, Markowitz GS, Appel GB, D'Agati VD.

    Kidney Int. 2006 Feb;69(3):616-20. No abstract available. PMID: 16514437 [PubMed - indexed for MEDLINE]Related articles

    20.

    Improved outcomes in nephrotic syndrome.

    Appel GB.

    Cleve Clin J Med. 2006 Feb;73(2):161-7. Review.PMID: 16478040 [PubMed - indexed for MEDLINE]Related articlesFree article

    21.

    Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis.

    Ginzler EM, Dooley MA, Aranow C, Kim MY, Buyon J, Merrill JT, Petri M, Gilkeson GS, Wallace DJ, Weisman MH, Appel GB.

    N Engl J Med. 2005 Nov 24;353(21):2219-28.PMID: 16306519 [PubMed - indexed for MEDLINE]Related articlesFree article

    22.

    Use of mycophenolate mofetil in autoimmune and renal diseases.

    Appel GB, Radhakrishnan J, Ginzler EM.

    Transplantation. 2005 Oct 15;80(2 Suppl):S265-71. Review.PMID: 16251859 [PubMed - indexed for MEDLINE]Related articles

    23.

    Mutational and Biological Analysis of alpha-actinin-4 in focal segmental glomerulosclerosis.

    Weins A, Kenlan P, Herbert S, Le TC, Villegas I, Kaplan BS, Appel GB, Pollak MR.

    J Am Soc Nephrol. 2005 Dec;16(12):3694-701. Epub 2005 Oct 26.PMID: 16251236 [PubMed - indexed for MEDLINE]Related articlesFree article

    24.

    Membranoproliferative glomerulonephritis type II (dense deposit disease): an update.

    Appel GB, Cook HT, Hageman G, Jennette JC, Kashgarian M, Kirschfink M, Lambris JD, Lanning L, Lutz HU, Meri S, Rose NR, Salant DJ, Sethi S, Smith RJ, Smoyer W, Tully HF, Tully SP, Walker P, Welsh M, Würzner R, Zipfel PF.

    J Am Soc Nephrol. 2005 May;16(5):1392-403. Epub 2005 Mar 30. Review.PMID: 15800116 [PubMed - indexed for MEDLINE]Related articlesFree article

    25.

    Angiotensin II receptor antagonists: role in hypertension, cardiovascular disease, and renoprotection.

    Appel GB, Appel AS.

    Prog Cardiovasc Dis. 2004 Sep-Oct;47(2):105-15. Review. No abstract available. PMID: 15586351 [PubMed - indexed for MEDLINE]Related articles

    26.

    The classification of glomerulonephritis in systemic lupus erythematosus revisited.

    Weening JJ, D'Agati VD, Schwartz MM, Seshan SV, Alpers CE, Appel GB, Balow JE, Bruijn JA, Cook T, Ferrario F, Fogo AB, Ginzler EM, Hebert L, Hill G, Hill P, Jennette JC, Kong NC, Lesavre P, Lockshin M, Looi LM, Makino H, Moura LA, Nagata M.

    J Am Soc Nephrol. 2004 Feb;15(2):241-50. Erratum in: J Am Soc Nephrol. 2004 Mar;15(3):835-6. PMID: 14747370 [PubMed - indexed for MEDLINE]Related articlesFree article

    27.

    The classification of glomerulonephritis in systemic lupus erythematosus revisited.

    Weening JJ, D'Agati VD, Schwartz MM, Seshan SV, Alpers CE, Appel GB, Balow JE, Bruijn JA, Cook T, Ferrario F, Fogo AB, Ginzler EM, Hebert L, Hill G, Hill P, Jennette JC, Kong NC, Lesavre P, Lockshin M, Looi LM, Makino H, Moura LA, Nagata M; International Society of Nephrology Working Group on the Classification of Lupus Nephritis; Renal Pathology Society Working Group on the Classification of Lupus Nephritis.

    Kidney Int. 2004 Feb;65(2):521-30. Review. Erratum in: Kidney Int. 2004 Mar;65(3):1132. PMID: 14717922 [PubMed - indexed for MEDLINE]Related articles

    28.

    Randomized trial of an inhibitor of formation of advanced glycation end products in diabetic nephropathy.

    Bolton WK, Cattran DC, Williams ME, Adler SG, Appel GB, Cartwright K, Foiles PG, Freedman BI, Raskin P, Ratner RE, Spinowitz BS, Whittier FC, Wuerth JP; ACTION I Investigator Group.

    Am J Nephrol. 2004 Jan-Feb;24(1):32-40. Epub 2003 Dec 17.PMID: 14685005 [PubMed - indexed for MEDLINE]Related articles

    29.

    Proliferative glomerulonephritis with monoclonal IgG deposits: a distinct entity mimicking immune-complex glomerulonephritis.

    Nasr SH, Markowitz GS, Stokes MB, Seshan SV, Valderrama E, Appel GB, Aucouturier P, D'Agati VD.

    Kidney Int. 2004 Jan;65(1):85-96.PMID: 14675039 [PubMed - indexed for MEDLINE]Related articles

    30.

    Prognosis in proliferative lupus nephritis: the role of socio-economic status and race/ethnicity.

    Barr RG, Seliger S, Appel GB, Zuniga R, D'Agati V, Salmon J, Radhakrishnan J.

    Nephrol Dial Transplant. 2003 Oct;18(10):2039-46.PMID: 13679478 [PubMed - indexed for MEDLINE]Related articlesFree article

    31.

    Hyperlipidemia and thrombotic complications in patients with membranous nephropathy.

    Nickolas TL, Radhakrishnan J, Appel GB.

    Semin Nephrol. 2003 Jul;23(4):406-11. Review.PMID: 12923730 [PubMed - indexed for MEDLINE]Related articles

    32.

    Analysis of metabolic parameters as predictors of risk in the RENAAL study.

    Appel GB, Radhakrishnan J, Avram MM, DeFronzo RA, Escobar-Jimenez F, Campos MM, Burgess E, Hille DA, Dickson TZ, Shahinfar S, Brenner BM; RENAAL Study.

    Diabetes Care. 2003 May;26(5):1402-7.PMID: 12716796 [PubMed - indexed for MEDLINE]Related articlesFree article

    33.

    Collapsing glomerulopathy.

    Schwimmer JA, Markowitz GS, Valeri A, Appel GB.

    Semin Nephrol. 2003 Mar;23(2):209-18. Review.PMID: 12704581 [PubMed - indexed for MEDLINE]Related articles

    34.

    Fibrillary and immunotactoid glomerulonephritis: Distinct entities with different clinical and pathologic features.

    Rosenstock JL, Markowitz GS, Valeri AM, Sacchi G, Appel GB, D'Agati VD.

    Kidney Int. 2003 Apr;63(4):1450-61.PMID: 12631361 [PubMed - indexed for MEDLINE]Related articles

    35.

    Membranous glomerulopathy and acute interstitial nephritis following treatment with celecoxib.

    Markowitz GS, Falkowitz DC, Isom R, Zaki M, Imaizumi S, Appel GB, D'Agati VD.

    Clin Nephrol. 2003 Feb;59(2):137-42.PMID: 12608557 [PubMed - indexed for MEDLINE]Related articles

    36.

    NPHS2 mutations in late-onset focal segmental glomerulosclerosis: R229Q is a common disease-associated allele.

    Tsukaguchi H, Sudhakar A, Le TC, Nguyen T, Yao J, Schwimmer JA, Schachter AD, Poch E, Abreu PF, Appel GB, Pereira AB, Kalluri R, Pollak MR.

    J Clin Invest. 2002 Dec;110(11):1659-66.PMID: 12464671 [PubMed - indexed for MEDLINE]Related articlesFree article

    37.

    Fludarabine treatment of cryoglobulinemic glomerulonephritis.

    Rosenstock JL, Stern L, Sherman WH, Appel GB, Radhakrishnan J.

    Am J Kidney Dis. 2002 Sep;40(3):644-8.PMID: 12200818 [PubMed - indexed for MEDLINE]Related articles

    38.

    Minimal change disease in systemic lupus erythematosus.

    Dube GK, Markowitz GS, Radhakrishnan J, Appel GB, D'Agati VD.

    Clin Nephrol. 2002 Feb;57(2):120-6.PMID: 11863121 [PubMed - indexed for MEDLINE]Related articles

    39.

    COX-2 inhibitors and the kidney.

    Appel GB.

    Clin Exp Rheumatol. 2001 Nov-Dec;19(6 Suppl 25):S37-40.PMID: 11695250 [PubMed - indexed for MEDLINE]Related articles

    40.

    Membranous glomerulopathy associated with graft-versus-host disease following allogeneic stem cell transplantation. Report of 2 cases and review of the literature.

    Lin J, Markowitz GS, Nicolaides M, Hesdorffer CS, Appel GB, D'Agati VD, Savage DG.

    Am J Nephrol. 2001 Sep-Oct;21(5):351-6. Review.PMID: 11684793 [PubMed - indexed for MEDLINE]Related articles

    41.

    Plasmapheresis treatment of recurrent FSGS in adult renal transplant recipients.

    Matalon A, Markowitz GS, Joseph RE, Cohen DJ, Saal SD, Kaplan B, D'Agati VD, Appel GB.

    Clin Nephrol. 2001 Oct;56(4):271-8.PMID: 11680656 [PubMed - indexed for MEDLINE]Related articles

    42.

    Racial and socioeconomic factors in glomerular disease.

    Halevy D, Radhakrishnan J, Appel GB.

    Semin Nephrol. 2001 Jul;21(4):403-10. Review.PMID: 11455529 [PubMed - indexed for MEDLINE]Related articles

    43.

    Renal monoclonal immunoglobulin deposition disease: the disease spectrum.

    Lin J, Markowitz GS, Valeri AM, Kambham N, Sherman WH, Appel GB, D'Agati VD.

    J Am Soc Nephrol. 2001 Jul;12(7):1482-92.PMID: 11423577 [PubMed - indexed for MEDLINE]Related articlesFree article

    44.

    Collapsing focal segmental glomerulosclerosis following treatment with high-dose pamidronate.

    Markowitz GS, Appel GB, Fine PL, Fenves AZ, Loon NR, Jagannath S, Kuhn JA, Dratch AD, D'Agati VD.

    J Am Soc Nephrol. 2001 Jun;12(6):1164-72.PMID: 11373339 [PubMed - indexed for MEDLINE]Related articlesFree article

    45.

    Cyclosporine in patients with steroid-resistant membranous nephropathy: a randomized trial.

    Cattran DC, Appel GB, Hebert LA, Hunsicker LG, Pohl MA, Hoy WE, Maxwell DR, Kunis CL; North America Nephrotic Syndrome Study Group.

    Kidney Int. 2001 Apr;59(4):1484-90.PMID: 11260412 [PubMed - indexed for MEDLINE]Related articlesFree article

    46.

    Antiphospholipid antibody syndrome and renal disease.

    Joseph RE, Radhakrishnan J, Appel GB.

    Curr Opin Nephrol Hypertens. 2001 Mar;10(2):175-81. Review.PMID: 11224691 [PubMed - indexed for MEDLINE]Related articles

    47.

    Membranous glomerulopathy with Bowman's capsular and tubular basement membrane deposits.

    Markowitz GS, Kambham N, Maruyama S, Appel GB, Cohen DJ, Kim RC, Andres GA, D'Agati VD.

    Clin Nephrol. 2000 Dec;54(6):478-86. Review.PMID: 11140809 [PubMed - indexed for MEDLINE]Related articles

    48.

    Treatment of focal segmental glomerulosclerosis.

    Matalon A, Valeri A, Appel GB.

    Semin Nephrol. 2000 May;20(3):309-17. Review.PMID: 10855941 [PubMed - indexed for MEDLINE]Related articles

    49.

    A randomized trial of cyclosporine in patients with steroid-resistant focal segmental glomerulosclerosis. North America Nephrotic Syndrome Study Group.

    Cattran DC, Appel GB, Hebert LA, Hunsicker LG, Pohl MA, Hoy WE, Maxwell DR, Kunis CL.

    Kidney Int. 1999 Dec;56(6):2220-6.PMID: 10594798 [PubMed - indexed for MEDLINE]Related articlesFree article

    50.

    Hepatitis C virus-associated glomerular disease in patients with human immunodeficiency virus coinfection.

    Cheng JT, Anderson HL Jr, Markowitz GS, Appel GB, Pogue VA, D'Agati VD.

    J Am Soc Nephrol. 1999 Jul;10(7):1566-74.PMID: 10405213 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    9 free full-text articles in PubMed Central

    Find related data

    Search details

    » See more...

    Recent activity